The Impact of Smoking on Clinical Outcomes after Percutaneous Coronary Intervention in Women Compared to Men
Table 3
Joint effect of smoking with gender and other risk factors.
MACE
Not-MACE
HR (95% CI)
Smoker (n, %)
80 (61.5%)
767 (46%)
1.27 (0.80–2.01)
0.300
Female (smoker/nonsmoker)
29 (22.3%)
184 (11%)
1.86 (1.23–2.82)
0.003
Male (smoker/nonsmoker)
51 (39.2)
583 (34.9)
1.12 (0.78–1.59)
0.527
Female (DM/non-DM)
21 (42.9)
251 (38.7)
1.38 (0.78–2.43)
0.262
Male (DM/non-DM)
23 (28.4)
238 (23.3)
1.34 (0.82–2.17)
0.230
Female (HTN/non-HTN)
35 (71.4)
478 (73.7)
0.96 (0.51–1.79)
0.909
Male (HTN/non-HTN)
38 (46.9)
448 (43.9)
1.17 (0.75–1.81)
0.470
Female (HLP/non-HLP)
31 (63.3)
423 (65.2)
0.92 (0.52–1.66)
0.804
Male (HLP/non-HLP)
31 (38.3)
432 (42.4)
0.83 (0.53–1.31)
0.440
MACE: major adverse cardiac events, HR: hazard ratio, CI: confidence interval, DM: diabetes mellitus, HTN: hypertension, and HLP: hyperlipidemia. Data are presented as number (%). Bold values imply significant differences.
